Chapter 5 Nociceptive Signals to TRPV1 and its Clinical Potential

Current Topics in Membranes

Volumn 57, Issue , 2006, Pages 151-180

  Oh, Uhtaek ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745640492     PISSN: 10635823     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1063-5823(06)57004-8     Document Type: Review

References (109)

1. Acs G., Lee J., Marquez V.E., and Blumberg P.M. Distinct structure-activity relations for stimulation of 45Ca uptake and for high affinity binding in cultured rat dorsal root ganglion neurons and dorsal root ganglion membranes. Brain Res. Mol. Brain Res. 35 (1996) 173-182
2. Ahluwalia J., Urban L., Capogna M., Bevan S., and Nagy I. Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons. Neuroscience 100 (2000) 685-688
3. Al-Hayani A., Wease K.N., Ross R.A., Pertwee R.G., and Davies S.N. The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 41 (2001) 1000-1005
4. Bauer M.B., Meller S.T., and Gebhart G.F. Bradykinin modulation of a spinal nociceptive reflex in the rat. Brain Res. 578 (1992) 186-196
5. Bevan S., and Szolcsanyi J. Sensory neuron-specific actions of capsaicin: Mechanisms and applications. Trends Pharmacol. Sci. 11 (1990) 330-333
6. Bevan S.J., and Docherty R.J. Cellular mechanisms of the action of capsaicin. In: Wood J. (Ed). "Cellular Mechanisms of the Action of Capsaicin" (1993), Academic Press, London 27-44
7. Burgess G.M., Mullaney I., McNeill M., Dunn P.M., and Rang H.P. Second messengers involved in the mechanism of action of bradykinin in sensory neurons in culture. J. Neurosci. 9 (1989) 3314-3325
8. Cadas H., di Tomaso E., and Piomelli D. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain. J. Neurosci. 17 (1997) 1226-1242
9. Calignano A., La Rana G., Giuffrida A., and Piomelli D. Control of pain initiation by endogenous cannabinoids. Nature 394 (1998) 277-281
10. Carr M.J., Kollarik M., Meeker S.N., and Undem B.J. A role for TRPV1 in bradykinin-induced excitation of vagal airway afferent nerve terminals. J. Pharmacol. Exp. Ther. 304 (2003) 1275-1279
11. Caterina M.J., Schumacher M.A., Tominaga M., Rosen T.A., Levine J.D., and Julius D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 389 (1997) 816-824
12. Clapham D.E. TRP channels as cellular sensors. Nature 426 (2003) 517-524
13. Contassot E., Tenan M., Schnuriger V., Pelte M.F., and Dietrich P.Y. Arachidonyl ethanolamide induces apoptosis of uterine cervix cancer cells via aberrantly expressed vanilloid receptor-1. Gynecol. Oncol. 93 (2004) 182-188
14. De Petrocellis L., Chu C.J., Moriello A.S., Kellner J.C., Walker J.M., and Di Marzo V. Actions of two naturally occurring saturated N-acyldopamines on transient receptor potential vanilloid 1 (TRPV1) channels. Br. J. Pharmacol. 143 (2004) 251-256
15. Devane W.A., and Axelrod J. Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc. Natl. Acad. Sci. USA 91 (1994) 6698-6701
16. Devane W.A., Hanus L., Breuer A., Pertwee R.G., Stevenson L.A., Griffin G., Gibson D., Mandelbaum A., Etinger A., and Mechoulam R. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 (1992) 1946-1949
17. Docherty R.J., Yeats J.C., and Piper A.S. Capsazepine block of voltage-activated calcium channels in adult rat dorsal root ganglion neurones in culture. Br. J. Pharmacol. 121 (1997) 1461-1467
18. Doherty E.M., Fotsch C., Bo Y., Chakrabarti P.P., Chen N., Gavva N., Han N., Kelly M.G., Kincaid J., Klionsky L., Liu Q., Ognyanov V.I., et al. Discovery of potent, orally available vanilloid receptor-1 antagonists: Structure-activity relationship of N-aryl cinnamides. J. Med. Chem. 48 (2005) 71-90
19. Dray A., and Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 3 (1993) 99-104
20. Ferreira J., da Silva G.L., and Calixto J.B. Contribution of vanilloid receptors to the overt nociception induced by B2 kinin receptor activation in mice. Br. J. Pharmacol. 141 (2004) 787-794
21. Ferreira S.H., Lorenzetti B.B., and Poole S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol. 110 (1993) 1227-1231
22. Fleming I. Cytochrome p450 and vascular homeostasis. Circ. Res. 89 (2001) 753-762
23. Gammon C.M., Allen A.C., and Morell P. Bradykinin stimulates phosphoinositide hydrolysis and mobilization of arachidonic acid in dorsal root ganglion neurons. J. Neurochem. 53 (1989) 95-101
24. Gavva N.R., Klionsky L., Qu Y., Shi L., Tamir R., Edenson S., Zhang T.J., Viswanadhan V.N., Toth A., Pearce L.V., Vanderah T.W., Porreca F., et al. Molecular determinants of vanilloid sensitivity in TRPV1. J. Biol. Chem. 279 (2004) 20283-20295
25. Gavva N.R., Tamir R., Qu Y., Klionsky L., Zhang T.J., Immke D., Wang J., Zhu D., Vanderah T.W., Porreca F., Doherty E.M., Norman M.H., et al. AMG 9810 [(E)-3-(4-t-Butylphenyl)-N-(2,3-dihydrobenzo[b][1,4] dioxin-6-yl)acrylamide], a Novel Vanilloid Receptor 1 (TRPV1) Antagonist with Antihyperalgesic Properties. J. Pharmacol. Exp. Ther. 313 (2005) 474-484
26. Ghilardi J.R., Rohrich H., Lindsay T.H., Sevcik M.A., Schwei M.J., Kubota K., Halvorson K.G., Poblete J., Chaplan S.R., Dubin A.E., Carruthers N.I., Swanson D., et al. Selective blockade of the capsaicin receptor TRPV1 attenuates bone cancer pain. J. Neurosci. 25 (2005) 3126-3131
27. Gill C.H., Randall A., Bates S.A., Hill K., Owen D., Larkman P.M., Cairns W., Yusaf S.P., Murdock P.R., Strijbos P.J., Powell A.J., Benham C.D., et al. Characterization of the human HCN1 channel and its inhibition by capsazepine. Br. J. Pharmacol. 143 (2004) 411-421
28. Gunthorpe M.J., Rami H.K., Jerman J.C., Smart D., Gill C.H., Soffin E.M., Luis Hannan S., Lappin S.C., Egerton J., Smith G.D., Worby A., Howett L., et al. Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology 46 (2004) 133-149
29. Handwerker H.O., Forster C., and Kirchhoff C. Discharge patterns of human C-fibers induced by itching and burning stimuli. J. Neurophysiol. 66 (1991) 307-315
30. Holzer P. Neural injury, repair, and adaptation in the GI tract. II. The elusive action of capsaicin on the vagus nerve. Am. J. Physiol. 275 (1998) G8-G13
31. Hong Y., and Abbott F.V. Behavioural effects of intraplantar injection of inflammatory mediators in the rat. Neuroscience 63 (1994) 827-836
32. Howlett A.C. Pharmacology of cannabinoid receptors. Annu. Rev. Pharmacol. Toxicol. 35 (1995) 607-634
33. Huang S.M., Bisogno T., Trevisani M., Al-Hayani A., De Petrocellis L., Fezza F., Tognetto M., Petros T.J., Krey J.F., Chu C.J., Miller J.D., Davies S.N., et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc. Natl. Acad. Sci. USA 99 (2002) 8400-8405
34. Hwang S.W., and Oh U. Hot channels in airways: Pharmacology of the vanilloid receptor. Curr. Opin. Pharmacol. 2 (2002) 235-242
35. Hwang S.W., Cho H., Kwak J., Lee S.Y., Kang C.J., Jung J., Cho S., Min K.H., Suh Y.G., Kim D., and Oh U. Direct activation of capsaicin receptors by products of lipoxygenases: Endogenous capsaicin-like substances. Proc. Natl. Acad. Sci. USA 97 (2000) 6155-6160
36. Imig J.D., Zou A.P., Stec D.E., Harder D.R., Falck J.R., and Roman R.J. Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles. Am. J. Physiol. 270 (1996) R217-R227
37. Jiang Y., Ruta V., Chen J., Lee A., and MacKinnon R. The principle of gating charge movement in a voltage-dependent K+ channel. Nature 423 (2003) 42-48
38. Jiang Y., Lee A., Chen J., Ruta V., Cadene M., Chait B.T., and MacKinnon R. X-ray structure of a voltage-dependent K+ channel. Nature 423 (2003) 33-41
39. Jordt S.E., and Julius D. Molecular basis for species-specific sensitivity to "hot" chili peppers. Cell 108 (2002) 421-430
40. Jung J., Hwang S.W., Kwak J., Lee S.Y., Kang C.J., Kim W.B., Kim D., and Oh U. Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel. J. Neurosci. 19 (1999) 529-538
41. Jung J., Lee S.-Y., Hwang S.W., Cho H., Shin J., Kang Y.-S., Kim S., and Oh U. Agonist recognition sites in the cytosolic tails of vanilloid receptor 1. J. Biol. Chem. 277 (2002) 44448-44454
42. Keele C., and Armstrong D. "Substances Producing Pain and Itch." (1964), Edward Arnold, London
43. Kim B.M., Lee S.H., Shim W.S., and Oh U. Histamine-induced Ca(2+) influx via the PLA(2)/lipoxygenase/TRPV1 pathway in rat sensory neurons. Neurosci. Lett. 361 (2004) 159-162
44. Kim D., Lewis D.L., Graziadei L., Neer E.J., Bar-Sagi D., and Clapham D.E. G-protein βγ_-subunits activate the cardiac muscarinic K+-channel via phosphorylase A2. Nature 337 (1989) 557-560
45. Koppert W., Reeh P.W., and Handwerker H.O. Conditioning of histamine by bradykinin alters responses of rat nociceptor and human itch sensation. Neurosci. Lett. 152 (1993) 117-120
46. Koppert W., Martus P., and Reeh P.W. Interactions of histamine and bradykinin on polymodal C-fibres in isolated rat skin. Eur. J. Pain 5 (2001) 97-106
47. Kumazawa T., Mizumura K., Minagawa M., and Tsujii Y. Sensitizing effects of bradykinin on the heat responses of the visceral nociceptor. J. Neurophysiol. 66 (1991) 1819-1824
48. Kumazawa T., Mizumura K., Koda H., and Fukusako H. EP receptor subtypes implicated in the PGE2-induced sensitization of polymodal receptors in response to bradykinin and heat. J. Neurophysiol. 75 (1996) 2361-2368
49. Kwak J.Y., Jung J.Y., Hwang S.W., Lee W.T., and Oh U. A capsaicin-receptor antagonist, capsazepine, reduces inflammation-induced hyperalgesic responses in the rat: Evidence for an endogenous capsaicin-like substance. Neuroscience 86 (1998) 619-626
50. Lang E., Novak A., Reeh P.W., and Handwerker H.O. Chemosensitivity of fine afferents from rat skin in vitro. J. Neurophysiol. 63 (1990) 887-901
51. Leurs R., Traiffort E., Arrang J.M., Tardivel-Lacombe J., Ruat M., and Schwartz J.C. Guinea pig histamine H1 receptor. II. Stable expression in Chinese hamster ovary cells reveals the interaction with three major signal transduction pathways. J. Neurochem. 62 (1994) 519-527
52. Levine J.D., Lau W., and Kwiat G. Leukotrien B4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science 225 (1984) 743-745
53. Lischetzki G., Rukwied R., Handwerker H.O., and Schmelz M. Nociceptor activation and protein extravasation induced by inflammatory mediators in human skin. Eur. J. Pain 5 (2001) 49-57
54. Liu L., and Simon S.A. A rapid capsaicin-activated current in rat trigeminal ganglion neurons. Proc. Natl. Acad. Sci. USA 91 (1994) 738-741
55. Liu L., and Simon S.A. Capsazepine, a vanilloid receptor antagonist, inhibits nicotinic acetylcholine receptors in rat trigeminal ganglia. Neurosci. Lett. 228 (1997) 29-32
56. Maccarrone M., Lorenzon T., Bari M., Melino G., and Finazzi-Agro A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J. Biol. Chem. 275 (2000) 31938-31945
57. Magerl W., Westerman R.A., Mohner B., and Handwerker H.O. Properties of transdermal histamine iontophoresis: Differential effects of season, gender, and body region. J. Invest. Dermatol. 94 (1990) 347-352
58. Martin H.A., Basbaum A.I., Goetzl E.J., and Levine J.D. Leukotriene B4 decreases the mechanical and thermal thresholds of C-fiber nociceptors in the hairy skin of the rat. J. Neurophysiol. 60 (1988) 438-445
59. McGiff J.C., and Quilley J. 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids and blood pressure. Curr. Opin. Nephrol. Hypertens. 10 (2001) 231-237
60. McGuirk S.M., and Dolphin A.C. G-protein mediation in nociceptive signal transduction: An investigation into the excitatory action of bradykinin in a rat sensory neurons. Neuroscience 49 (1992) 117-128
61. Michaelis M., Vogel C., Blenk K.H., Arnarson A., and Janig W. Inflammatory mediators sensitize acutely axotomized nerve fibers to mechanical stimulation in the rat. J. Neurosci. 18 (1998) 7581-7587
62. Montell C., Birnbaumer L., Flockerzi V., Bindels R.J., Bruford E.A., Caterina M.J., Clapham D.E., Harteneck C., Heller S., and Julius D. A unified nomenclature for the superfamily of TRP cation channels. Mol. Cell 9 (2002) 229-231
63. Nicolson T.A., Bevan S., and Richards C.D. Characterization of the calcium responses to histamine in capsaicin-sensitive and capsaicin-insensitive sensory neurones. Neuroscience 110 (2002) 329-338
64. Nilius B., Vriens J., Prenen J., Droogmans G., and Voets T. TRPV4 calcium entry channel: A paradigm for gating diversity. Am. J. Physiol. Cell Physiol. 286 (2004) C195-C205
65. Oh U., Hwang S.W., and Kim D. Capsaicin activates a nonselective cation channel in cultured neonatal rat dorsal root ganglion neurons. J. Neurosci. 16 (1996) 1659-1667
66. Piomelli D., Volterra A., Dale N., Siegelbaum S.A., Kandel E.R., Schwartz J.H., and Belardetti F. Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells. Nature 328 (1987) 38-43
67. Pomonis J.D., Harrison J.E., Mark L., Bristol D.R., Valenzano K.J., and Walker K. N-(4-Tertiarybutylphenyl)-4-(3-cholorphyridin-2-yl)tetrahydropyrazine -1(2H)- carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: II. In vivo characterization in rat models of inflammatory and neuropathic pain. J. Pharmacol. Exp. Ther. 306 (2003) 387-393
68. Reeh P.W. Sensory receptors in a mammalian skin-nerve in vitro preparation. Prog. Brain Res. 74 (1988) 271-276
69. Reeh P.W., and Petho G. Nociceptor excitation by thermal sensitization-a hypothesis. Prog. Brain Res. 129 (2000) 39-50
70. Ring J. Plasma histamine concentrations in atopic eczema. Clin. Allergy 13 (1983) 545-552
71. Roman R.J. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Physiol. Rev. 82 (2002) 131-185
72. Rousseau E., Cloutier M., Morin C., and Proteau S. Capsazepine, a vanilloid antagonist, abolishes tonic responses induced by 20-HETE on guinea pig airway smooth muscle. Am. J. Physiol. Lung Cell Mol. Physiol. 288 (2005) L460-L470
73. Ruzicka T., and Gluck S. Cutaneous histamine levels and histamine releasability from the skin in atopic dermatitis and hyper-IgE-syndrome. Arch. Dermatol. Res. 275 (1983) 41-44
74. Sanchez J.F., Krause J.E., and Cortright D.N. The distribution and regulation of vanilloid receptor VR1 and VR1 5′ splice variant RNA expression in rat. Neuroscience 107 (2001) 373-381
75. Schmelz M., Schmidt R., Bickel A., Handwerker H.O., and Torebjork H.E. Specific C-receptors for itch in human skin. J. Neurosci. 17 (1997) 8003-8008
76. Schmelz M., Schmidt R., Weidner C., Hilliges M., Torebjork H.E., and Handwerker H.O. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J. Neurophysiol. 89 (2003) 2441-2448
77. Schumacher M.A., Moff I., Sudanagunta S.P., and Levine J.D. Molecular cloning of an N-terminal splice variant of the capsaicin receptor. Loss of N-terminal domain suggests functional divergence among capsaicin receptor subtypes. J. Biol. Chem. 275 (2000) 2756-2762
78. Scotland R.S., Chauhan S., Davis C., De Felipe C., Hunt S., Kabir J., Kotsonis P., Oh U., and Ahluwalia A. Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: A novel mechanism involved in myogenic constriction. Circ. Res. 95 (2004) 1027-1034
79. Seabrook G.R., Sutton K.G., Jarolimek W., Hollingworth G.J., Teague S., Webb J., Clark N., Boyce S., Kerby J., Ali Z., Chou M., Middleton R., et al. Functional properties of the high-affinity TRPV1 (VR1) vanilloid receptor antagonist (4-hydroxy-5-iodo-3-methoxyphenylacetate ester) iodo-resiniferatoxin. J. Pharmacol. Exp. Ther. 303 (2002) 1052-1060
80. Shin C.Y., Shin J., Kim B.M., Wang M.H., Jang J.H., Surh Y.J., and Oh U. Essential role of mitochondrial permeability transition in vanilloid receptor 1-dependent cell death of sensory neurons. Mol. Cell. Neurosci. 24 (2003) 57-68
81. Shin J., Cho H., Hwang S.W., Jung J., Shin C.Y., Lee S.Y., Kim S.H., Lee M.G., Choi Y.H., Kim J., Haber N.A., Reichling D.B., et al. Bradykinin-12-lipoxygenase-VR1 signaling pathway for inflammatory hyperalgesia. Proc. Natl. Acad. Sci. USA 99 (2002) 10150-10155
82. Shin J.S., Wang M.H., Hwang S.W., Cho H., Cho S.Y., Kwon M.J., Lee S.Y., and Oh U. Differences in sensitivity of vanilloid receptor 1 transfected to human embryonic kidney cells and capsaicin-activated channels in cultured rat dorsal root ganglion neurons to capsaicin receptor agonists. Neurosci. Lett. 299 (2001) 135-139
83. Simone D.A., Ngeow J.Y.F., Putterman G.J., and Lamotte R.H. Hyperalgesia to heat after intradermal injection of capsaicin. Brain Res. 418 (1987) 201-203
84. Simone D.A., Baumann T.K., and Lamotte R.H. Dose-dependent pain and mechanical hyperalgesia in humans after intradermal injection of capsaicin. Pain 38 (1989) 99-107
85. Stander S., Steinhoff M., Schmelz M., Weisshaar E., Metze D., and Luger T. Neurophysiology of pruritus: Cutaneous elicitation of itch. Arch. Dermatol. 139 (2003) 1463-1470
86. Steen K.H., Steen A.E., and Reeh P.W. A dominant role of acid pH in inflammatory excitation and sensitization of nociceptors in rat skin, in vitro. J. Neurosci. 15 (1995) 3982-3989
87. Suh Y.G., Lee Y.S., Min K.H., Park O.H., Seung H.S., Kim H.D., Park H.G., Choi J., Lee J., Kang S.W., Oh U.T., Koo J.Y., et al. Novel non-vanilloid VR1 antagonist of high analgesic effects and its structural requirement for VR1 antagonistic effects. Bioorg. Med. Chem. Lett. 13 (2003) 4389-4393
88. Sun Q., Tafesse L., Islam K., Zhou X., Victory S.F., Zhang C., Hachicha M., Schmid L.A., Patel A., Rotshteyn Y., Valenzano K.J., Kyle D.J., et al. 4-(2-pyridyl)piperazine-1-carboxamides: Potent vanilloid receptor 1 antagonists. Bioorg. Med. Chem. Lett. 13 (2003) 3611-3616
89. Swanson D.M., Dubin A.E., Shah C., Nasser N., Chang L., Dax S.L., Jetter M., Breitenbucher J.G., Liu C., Mazur C., Lord B., Gonzales L., et al. Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist. J. Med. Chem. 48 (2005) 1857-1872
90. Szallasi A., and Blumberg P.M. Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes. Brain Res. 524 (1990) 106-111
91. Szallasi A., and Blumberg P.M. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev. 51 (1999) 159-212
92. Szallasi A., Blumberg P.M., Nilsson S., Hokfelt T., and Lundberg J.M. Visualization by [3H]resiniferatoxin autoradiography of capsaicin-sensitive neurons in the rat, pig and man. Eur. J. Pharmacol. 264 (1994) 217-221
93. Szallasi A., Blumberg P.M., Annicelli L.L., Krause J.E., and Cortright D.N. The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons. Mol. Pharmacol. 56 (1999) 581-587
94. Szolcsanyi J. Actions of capsaicin on sensory receptors. In: Wood J. (Ed). "Actions of Capsaicin on Sensory Receptors" (1993), Academic Press, London 1-26
95. Szolcsanyi J., and Jancso-Gabor A. Sensory effects of capsaicin congeners II. Importance of chemical structure and pungency in desensitizing activity of capsaicin-type compounds. Drug Res. 26 (1976) 33-37
96. Tafesse L., Sun Q., Schmid L., Valenzano K.J., Rotshteyn Y., Su X., and Kyle D.J. Synthesis and evaluation of pyridazinylpiperazines as vanilloid receptor 1 antagonists. Bioorg. Med. Chem. Lett. 14 (2004) 5513-5519
97. Thayer S.A., Perney T.M., and Miller R.J. Regulation of calcium homeostasis in sensory neurons by bradykinin. J. Neurosci. 8 (1988) 4089-4097
98. Tominaga M., Caterina M.J., Malmberg A.B., Rosen T.A., Gilbert H., Skinner K., Raumann B.E., Basbaum A.I., and Julius D. The cloned capsaicin receptor integrates multiple pain-producing stimuli. Neuron 21 (1998) 531-543
99. Valenzano K.J., Grant E.R., Wu G., Hachicha M., Schmid L., Tafesse L., Sun Q., Rotshteyn Y., Francis J., Limberis J., Malik S., Whittemore E.R., et al. N-(4-tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a novel, orally effective vanilloid receptor 1 antagonist with analgesic properties: I. In vitro characterization and pharmacokinetic properties. J. Pharmacol. Exp. Ther. 306 (2003) 377-386
100. Wahl P., Foged C., Tullin S., and Thomsen C. Iodo-resiniferatoxin, a new potent vanilloid receptor antagonist. Mol. Pharmacol. 59 (2001) 9-15
101. Walpole C.S., Bevan S., Bovermann G., Boelsterli J.J., Breckenridge R., Davies J.W., Hughes G.A., James I., Oberer L., Winter J., and Wrigglesworth R. The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin. J. Med. Chem. 37 (1994) 1942-1954
102. Walpole C.S.J., and Wrigglesworth R. Structural requirements for capsaicin agonists and antagonists. In: Wood J. (Ed). "Structural Requirements for Capsaicin Agonists and Antagonists" (1993), Academic Press, London 63-81
103. Wang Y., Szabo T., Welter J.D., Toth A., Tran R., Lee J., Kang S.U., Suh Y.G., and Blumberg P.M. High affinity antagonists of the vanilloid receptor. Mol. Pharmacol. 62 (2002) 947-956
104. Wang Y., Toth A., Tran R., Szabo T., Welter J.D., Blumberg P.M., Lee J., Kang S.U., and Lim J.O. High-affinity partial agonists of the vanilloid receptor. Mol. Pharmacol. 64 (2003) 325-333
105. Ward L., Wright E., and McMahon S.B. A comparison of the effects of noxious and innocuous counterstimuli on experimentally induced itch and pain. Pain 64 (1996) 129-138
106. Wehmeyer K.R., Kasting G.B., Powell J.H., Kuhlenbeck D.L., Underwood R.A., and Bowman L.A. Application of liquid chromatography with on-line radiochemical detection to metabolism studies on a novel class of analgesics. J. Pharm. Biomed. Anal. 8 (1990) 177-183
107. Winter J., Dray A., Wood J.N., Yeats J.C., and Bevan S. Cellular mechanism of action of resiniferatoxin: A potent sensory neuron excitotoxin. Brain Res. 520 (1990) 131-140
108. Wood J.N., Winter J., James I.F., Rang H.P., Yeats J., and Bevan S. Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture. J. Neurosci. 8 (1988) 3208-3220
109. Zygmunt P.M., Petersson J., Andersson D.A., Chuang H., Sorgard M., Di Marzo V., Julius D., and Hogestatt E.D. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400 (1999) 452-457